SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$45.50
-0.59 (-1.28%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Price Target
Analyst Price Target
+56.7% upside
Low Target
$54.07
Average Target
$71.29
High Target
$91.55
Current Price
$45.50
Current
$45.50
$45.50
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Scenario Analysis
Bear Case
$54.07
18.8%
Low target
Base Case
$71.29
+56.7%
Avg target
Bull Case
$91.55
+101.2%
High target
Risk/Reward
5.4x
Highly favorable
Price in Context
52-Week High
$61.76
-26.3% from high
52-Week Low
$27.07
+68.1% from low
50-Day SMA
$47.67
-4.6% vs SMA
200-Day SMA
$48.19
-5.6% vs SMA
RSI (14)
71.8
Overbought
Target vs 52W High
$71.29
+15.4% vs high
Next Earnings Report
Nov 10, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.86
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |